- Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en Europe
- Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe
- Crossject annonce le lancement d’une augmentation de capital
- Crossject communique ses résultats financiers audités pour 2023
- Crossject reports audited financial results for 2023
- Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
- Crossject trading on Euronext to resume as usual on Wednesday April 3
- La cotation sur l’action de Crossject à Euronext reprendra comme d’habitude le mercredi 3 avril
- Crossject advances in its U.S. Strategy and reports Financial Results for 2023
- Crossject poursuit sa stratégie de développement aux États-Unis et publie ses résultats financiers pour 2023
More ▼
Key statistics
As of last trade, Crossject SA (ALCJ:PAR) traded at 2.18, 18.98% above the 52 week low of 1.83 set on Apr 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.14 |
---|---|
High | 2.18 |
Low | 2.14 |
Bid | 2.17 |
Offer | 2.18 |
Previous close | 2.14 |
Average volume | 71.78k |
---|---|
Shares outstanding | 36.76m |
Free float | 22.74m |
P/E (TTM) | -- |
Market cap | 78.49m EUR |
EPS (TTM) | -0.2624 EUR |
Data delayed at least 15 minutes, as of May 07 2024 14:40 BST.
More ▼